|
|
|
|
|
Moxifloxacin hydrochloride |
|
BAY-12-8039 |
|
186826-86-8 |
|
Usage: Antibacterial drugs used in the treatment of community acquired pneumonia in acute exacerbation of chronic bronchitis in genitourinary infection of acute sinusitis curative effect remarkable |
|
EnglishAlias:AVALOX BAY-12-8039 (1's,6's)-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylicacidhydrochloride 1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-8-METHOXY-7-[(4AS,7AS)-OCTAHYDRO-6H-PYRROLO[3,4-B]PYRIDIN-6-YL]-4-OXO-3-QUINOLINECARBOXYLICACIDHYDROCHLORIDE 1-CYCLOPROPYL-7-[(S,S)-2,8-DIAZA-BICYCLO[4.3.0]NON-8-YL]-6-FLUORO-8-METHOXY-1,4-DIHYDRO-4-OXO-3-QUINOLINECARBOXYLICACIDHYDROCHLORIDE ACTIRA PROFLOX MOXIFLOXACINHCL 1-cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylicacidhydrochloride(1:1) 1-cyclopropyl-6-fluoro-8-methoxy-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride (1:1) Assay: 99% Package: 1kg ( based on customer needs) Appearance: Brown solid powder¡¡ CAS NO: 186826-86-8 MF: C21H24FN3O4.HCl InChI:InChI=1/C21H24FN3O4.ClH/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24 /h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28) 1H MW: 437.90 ¡¡¡¡ Boiling point: 636.4¡ÆC at 760 mmHg
|
|
|
|
|
|
|
|
ÀÌÁ¦Ç°¿¡ ´ëÇØ µî·ÏµÈ ÆǸž÷ü°¡ ¾ø½À´Ï´Ù. |
|
|
|
|
|